Home » Topics » Regulatory » Patents

Patents
RSS

SCRAS discloses novel topoisomerase inhibitors

Feb. 25, 1997

Zeneca discloses agents for pain associated with inflammation

Feb. 25, 1997

Novel vasopressin antagonists from Fujisawa

Feb. 21, 1997

Fibrinogen antagonists from Glaxo Wellcome

Feb. 21, 1997

Sanofi Winthrop reveals calpain inhibitors

Feb. 21, 1997

Novel rapamycin derivatives reported by Novartis

Feb. 21, 1997

Alcon describes dihydropyridines for ocular use

Feb. 21, 1997

Relaxin-like factor and relaxin analogues described

Feb. 21, 1997

Biorex discloses antiischemic agents

Feb. 20, 1997

Subtype-selective 5-HT1 antagonists from Pierre Fabre

Feb. 20, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...